Literature DB >> 28652998

Association of primary tumor lymph node ratio with burden of liver metastases and survival in stage IV colorectal cancer.

Ali Ahmad1, Jeffrey Reha1, Abdul Saied1,2, N Joseph Espat1,2, Ponnandai Somasundar1,2, Steven C Katz1,2.   

Abstract

BACKGROUND: The primary objective of our study was to assess the association of primary tumor lymph node ratio (LNR) in stage IV colorectal adenocarcinomas (CRC) with overall survival (OS) and the extent of metastatic disease in the liver.
METHODS: We analyzed data on 53 stage IV CRC patients who underwent surgical resection of the primary tumor. The median LNR of 0.25 was used to stratify patients into high LNR (H-LNR) and low LNR (L-LNR) groups. Statistical comparison was performed using chi square test and multiple regression models. OS was calculated using the Kaplan-Meier (KM) method while cox regression was used for multivariate analysis.
RESULTS: H-LNR status was associated with the presence of >3 liver metastases (LM) [odds ratio (OR): 2.43, P=0.047] and bilobar LM (OR: 3.94, P=0.039). The OS in H-LNR patients was significantly worse in the entire cohort compared to L-LNR (9% vs. 34% at 3 years, P=0.027). The 5-year OS in patients undergoing liver resection for LM was also significantly worse in the H-LNR group (0% vs. 37%, P=0.013). LNR was independently associated with survival on multivariate analysis [HR: 2.63; 95% confidence intervals (CI), 1.13-6.14; P=0.025].
CONCLUSIONS: In stage IV CRC, LNR is associated with the extent of hepatic tumor burden and was an independent predictor of survival in patients undergoing liver resection.

Entities:  

Keywords:  Colorectal cancer (CRC); liver metastases (LM); lymph node ratio (LNR); survival

Year:  2017        PMID: 28652998      PMCID: PMC5474451          DOI: 10.21037/hbsn.2016.08.08

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  28 in total

1.  Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone curative resection.

Authors:  Tsuyoshi Ozawa; Soichiro Ishihara; Takeshi Nishikawa; Toshiaki Tanaka; Junichiro Tanaka; Tomomichi Kiyomatsu; Keisuke Hata; Kazushige Kawai; Hiroaki Nozawa; Takamitsu Kanazawa; Shinsuke Kazama; Hironori Yamaguchi; Eiji Sunami; Joji Kitayama; Toshiaki Watanabe
Journal:  Ann Surg Oncol       Date:  2014-11-15       Impact factor: 5.344

2.  Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.

Authors:  Carlos A Vaccaro; Victor Im; Gustavo L Rossi; Guillermo Ojea Quintana; Mario L Benati; Diego Perez de Arenaza; Fernando A Bonadeo
Journal:  Dis Colon Rectum       Date:  2009-07       Impact factor: 4.585

3.  The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients.

Authors:  Robert Rosenberg; Jutta Engel; Christiane Bruns; Wolfgang Heitland; Nikolaus Hermes; Karl-Walter Jauch; Reinhard Kopp; Eberhard Pütterich; Reinhard Ruppert; Tibor Schuster; Helmut Friess; Dieter Hölzel
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

4.  Initial presentation with stage IV colorectal cancer: how aggressive should we be?

Authors:  S A Rosen; J F Buell; A Yoshida; S Kazsuba; R Hurst; F Michelassi; J M Millis; M C Posner
Journal:  Arch Surg       Date:  2000-05

5.  Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history.

Authors:  J Scheele; R Stangl; A Altendorf-Hofmann
Journal:  Br J Surg       Date:  1990-11       Impact factor: 6.939

6.  Log odds of positive lymph nodes as a prognostic indicator in stage IV colorectal cancer patients undergoing curative resection.

Authors:  Tsuyoshi Ozawa; Soichiro Ishihara; Eiji Sunami; Joji Kitayama; Toshiaki Watanabe
Journal:  J Surg Oncol       Date:  2015-02-17       Impact factor: 3.454

7.  Revised TN categorization for colon cancer based on national survival outcomes data.

Authors:  Leonard L Gunderson; John Milburn Jessup; Daniel J Sargent; Frederick L Greene; Andrew K Stewart
Journal:  J Clin Oncol       Date:  2009-11-30       Impact factor: 44.544

8.  The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer.

Authors:  Frédérique Peschaud; Peschaud Frédérique; Stéphane Benoist; Benoist Stéphane; Catherine Julié; Julié Catherine; Alain Beauchet; Beauchet Alain; Christophe Penna; Penna Christophe; Philippe Rougier; Rougier Philippe; Bernard Nordlinger
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

9.  A lymph node ratio of 10% is predictive of survival in stage III colon cancer: a French regional study.

Authors:  Charles Sabbagh; François Mauvais; Cyril Cosse; Lionel Rebibo; Jean-Paul Joly; Didier Dromer; Christine Aubert; Sophie Carton; Bernard Dron; Innocenti Dadamessi; Bernard Maes; Guillaume Perrier; David Manaouil; Jean-François Fontaine; Michel Gozy; Xavier Panis; Pierre Henri Foncelle; Hugues de Fresnoy; Fabien Leroux; Pierre Vaneslander; Caroline Ghighi; Jean-Marc Regimbeau
Journal:  Int Surg       Date:  2014 Jul-Aug

10.  Effect of specialist decision-making on treatment strategies for colorectal liver metastases.

Authors:  R P Jones; J-N Vauthey; R Adam; M Rees; D Berry; R Jackson; N Grimes; S W Fenwick; G J Poston; H Z Malik
Journal:  Br J Surg       Date:  2012-09       Impact factor: 6.939

View more
  10 in total

1.  Association between the lymph node ratio and hepatic tumor burden: importance for resectable colorectal liver metastases?

Authors:  Kristoffer Watten Brudvik; Kjetil Søreide
Journal:  Hepatobiliary Surg Nutr       Date:  2018-06       Impact factor: 7.293

2.  Primary lymph node ratio and hepatic resection for colorectal metastases.

Authors:  Daniel Ansari; William Torén; Roland Andersson
Journal:  Hepatobiliary Surg Nutr       Date:  2018-04       Impact factor: 7.293

3.  Nodal grouping in nasopharyngeal carcinoma: prognostic significance, N classification, and a marker for the identification of candidates for induction chemotherapy.

Authors:  Yifei Liu; Shenghuan Chen; Annan Dong; Fei Ai; Tingting Quan; Chunyan Cui; Jian Zhou; Shaobo Liang; Jiamin Wang; Shunxin Wang; Ling Hua; Shuoyu Xu; Mingyuan Chen; Ying Sun; Haojiang Li; Lizhi Liu
Journal:  Eur Radiol       Date:  2019-12-06       Impact factor: 5.315

4.  OTUB1 Recruits Tumor Infiltrating Lymphocytes and Is a Prognostic Marker in Digestive Cancers.

Authors:  Wenhao Zhang; Wenlong Qiu
Journal:  Front Mol Biosci       Date:  2020-11-06

Review 5.  The role of myeloid-derived suppressor cells in gastrointestinal cancer.

Authors:  Cheng Cui; Penglin Lan; Li Fu
Journal:  Cancer Commun (Lond)       Date:  2021-03-27

Review 6.  PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy.

Authors:  Junyu Long; Jianzhen Lin; Anqiang Wang; Liangcai Wu; Yongchang Zheng; Xiaobo Yang; Xueshuai Wan; Haifeng Xu; Shuguang Chen; Haitao Zhao
Journal:  J Hematol Oncol       Date:  2017-08-03       Impact factor: 17.388

Review 7.  Beyond N staging in colorectal cancer: Current approaches and future perspectives.

Authors:  Gianluca Arrichiello; Mario Pirozzi; Bianca Arianna Facchini; Sergio Facchini; Fernando Paragliola; Valeria Nacca; Antonella Nicastro; Maria Anna Canciello; Adele Orlando; Marianna Caterino; Davide Ciardiello; Carminia Maria Della Corte; Morena Fasano; Stefania Napolitano; Teresa Troiani; Fortunato Ciardiello; Giulia Martini; Erika Martinelli
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

8.  Prognostic Value of Lymph Node Ratio in Patients with Resected Synchronous Colorectal Liver Metastases and Less Than 12 Examined Lymph Nodes.

Authors:  Sorin Tiberiu Alexandrescu; Florin M Selaru; Andrei S Diaconescu; Cristian A Zlate; Diana Blanita; Razvan T Grigorie; Narcis O Zarnescu; Vlad Herlea; Irinel Popescu
Journal:  J Gastrointest Surg       Date:  2021-07-13       Impact factor: 3.452

9.  Lymph node ratio as a valuable prognostic factor for patients with colorectal liver-only metastasis undergoing curative resection.

Authors:  Yuxiang Deng; Jianhong Peng; Yujie Zhao; Qiaoqi Sui; Ruixia Zhao; Zhenhai Lu; Miaozhen Qiu; Junzhong Lin; Zhizhong Pan
Journal:  Cancer Manag Res       Date:  2018-07-17       Impact factor: 3.989

10.  Hepatobiliary case report and literature review of hepatic reactive lymphoid hyperplasia with positive anti-smooth muscle antibody and anti-nuclear antibody tests.

Authors:  Yong-Chang Zheng; Fu-Cun Xie; Kai Kang; Yue Shi; Yi-Lei Mao; Xin-Ting Sang; Shun-Da Du
Journal:  Transl Cancer Res       Date:  2019-06       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.